Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.
Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors.
复制标题
使用癌症特异性基因组重排来量化实体瘤患者血浆中的疾病负担。
DOI:
10.1002/gcc.20815
复制
发表时间:
2010-11
影响因子:
3.7
通讯作者:
Campbell, Peter J.
中科院分区:
文献类型:
--
作者:
McBride, David J.;Orpana, Arto K.;Sotiriou, Christos;Joensuu, Heikki;Stephens, Philip J.;Mudie, Laura J.;Hamalainen, Eija;Stebbings, Lucy A.;Andersson, Leif C.;Flanagan, Adrienne M.;Durbecq, Virginie;Ignatiadis, Michail;Kallioniemi, Olli;Heckman, Caroline A.;Alitalo, Kari;Edgren, Henrik;Futreal, P. Andrew;Stratton, Michael R.;Campbell, Peter J.
Detection of recurrent somatic rearrangements routinely allows monitoring of residual disease burden in leukemias, but is not used for most solid tumors. However, next-generation sequencing now allows rapid identification of patient-specific rearrangements in solid tumors. We mapped genomic rearrangements in three cancers and showed that PCR assays for rearrangements could detect a single copy of the tumor genome in plasma without false positives. Disease status, drug responsiveness, and incipient relapse could be serially assessed. In future, this strategy could be readily established in diagnostic laboratories, with major impact on monitoring of disease status and personalizing treatment of solid tumors.
登录
查看更多内容
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
17.1
作者:
Leary RJ;Kinde I;Diehl F;Schmidt K;Clouser C;Duncan C;Antipova A;Lee C;McKernan K;De La Vega FM;Kinzler KW;Vogelstein B;Diaz LA Jr;Velculescu VE
通讯作者:
Velculescu VE
DOI:
10.1038/nrc1299
发表时间:
2004-03
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1073/pnas.0507904102
发表时间:
2005-11-08
影响因子:
11.1
作者:
Diehl, F;Li, M;Vogelstein, B
通讯作者:
Vogelstein, B
影响因子:
82.9
作者:
Nawroz, H;Koch, W;Sidransky, D
通讯作者:
Sidransky, D